Wasat Mansoor

10.3k citations
98 papers · 3.1k indexed · 3 hit papers · h-index 23
Topics
Gastric Cancer Management and Outcomes (53 papers)Esophageal Cancer Research and Treatment (30 papers)Neuroendocrine Tumor Research Advances (30 papers)

In The Last Decade

Wasat Mansoor

95 papers receiving 3.1k citations

Hit Papers

Epirubicin, oxaliplatin, and capecitabine with or without...2013202620172021201320132017100200300400500

Peers

Wasat Mansoor
Comparison fields: 5 of 90
  • Oncology 1.9k
  • Pulmonary and Respiratory Medicine 1.9k
  • Surgery 1.0k
  • Gastroenterology 655
  • Epidemiology 530
Replace Heung Moon Chang with:
Heung Moon Chang South Korea
Masashi Ueno Japan
Klaus Gellert Germany
Éveline Boucher France
Olivıer Turrini France
Harald Schmalenberg Germany
Antoine Adenis France
Paolo G. Gobbi Italy
Isabelle Ray‐Coquard France
A. Lecesne France
Wasat Mansoor relative to Heung Moon Chang South Korea Heung Moon Chang's profile →
Citations per field
00.5×11.3×
Heung Moon Chang · 1×
Citations per year

Countries citing papers authored by Wasat Mansoor

Since Specialization
Citations

This map shows the geographic impact of Wasat Mansoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wasat Mansoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wasat Mansoor more than expected).

Fields of papers citing papers by Wasat Mansoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wasat Mansoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wasat Mansoor. The network helps show where Wasat Mansoor may publish in the future.

Co-authorship network of co-authors of Wasat Mansoor

This figure shows the co-authorship network connecting the top 25 collaborators of Wasat Mansoor. A scholar is included among the top collaborators of Wasat Mansoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wasat Mansoor. Wasat Mansoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 27
3 4
4 1
5 0
6 6
7 4
8 98
9 27
10 12
11 30
12 11
13
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studybreakdown →
391
14 10
15 3
16 2
17 28
18 150
19
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialbreakdown →
547
20 28

About Wasat Mansoor

Wasat Mansoor is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 98 papers that have together received 3.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (53 papers), Esophageal Cancer Research and Treatment (30 papers) and Neuroendocrine Tumor Research Advances (30 papers). The work is most often cited by research in Gastroenterology (655 citations), Oncology (1.9k citations) and Pulmonary and Respiratory Medicine (1.9k citations). Wasat Mansoor has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include David Cunningham, Stephen Falk, Fareeda Y. Coxon, Ian Chau, Jonathan Wadsley, Gary Middleton, Eric Van Cutsem, Alicia Okines, Kohei Shitara and David Ferry. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026